Summit Securities Group’s Terns Pharmaceuticals TERN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-184
Closed -$508 1265
2025
Q1
$508 Buy
+184
New +$508 ﹤0.01% 585